|This report contains新冠肺炎具体更新。
抗生素：技术和全球市场
报告亮点
The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025.
报告包括
- 28 data tables and 16 additional tables
- Comprehensive overview of the global market for antibiotics within the pharmaceutical industry
- Analyses of the global market trends, with data corresponding to market size for 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
- 评估预测期内市场增长，并深入研究产品类型，产品，管理途径，最终用户和地理区域的市场份额分析数据基础
- Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
- COVID-19对抗生素药物市场的影响以及短期与长期影响的前景，以及Covid-19的大流行
- 确定这些公司最能根据其专有技术，并购交易，合作，JVS和其他战略联盟来满足全球市场需求的定位。
- Detailed company profiles of the major global corporations, including Abbott, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Sanofi
报告范围
The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potentiality of antibiotics with detailed analysis of competitive environment between the companies. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment will be covered in the current report. The report covers a market projection for 2025, and a market share for key players.
该报告根据产品类型，管理途径，应用和地理位置将抗生素市场片段段。根据产品类型，市场被分割为细胞壁抑制剂，蛋白质抑制剂，DNA抑制剂和其他抑制剂（RNA，霉菌酸，叶酸）。根据行政途径，市场被细分为口头和局部。市场也基于应用类型提出，该应用程序进一步分为人类和兽医。
根据地理位置，市场已被细分为北美，欧洲，亚太地区，南美，中东和非洲地区。对美国，德国，英国，法国，西班牙，日本，中国，印度，巴西，墨西哥，GCC国家和南非等主要国家的详细分析。对于市场估计，将为2019年提供数据，为基准年，估计为2020年，预测价值为2025年。
Analyst Credentials
BCC出版人员组成的专家分析师组成，他们擅长进行主要研究，二级研究和数据分析，并拥有数十年的综合经验，这些经验涵盖了包括医疗保健，高级材料和新兴技术在内的广泛行业。总的来说，该团队代表了一系列多样化的教育成就，在微生物学，电气工程，企业管理和手术等领域完成了个人研究生工作。
报告亮点
全球系统性抗生素市场在2020年应从2015年的近406亿美元上升到近447亿美元，从2015年到2020年，复合年度增长率（CAGR）为2.0％。
报告包括
- An overview of the global markets and related technologies for antibiotics.
- 对全球市场趋势的分析，以及2014年，2015年的数据，以及至2020年复合年增长率（CAGR）的预测。
- 人类应用和兽医应用销售的市场细分
- 查看主要市场趋势以及驱动或抑制全球药物抗生素市场及其各种子市场的增长的因素
- Profiles of key players in the market and analysis of their core competencies and market shares
- 详细的覆盖范围
- β– lactams。
- 青霉素。
- Cephalosporins.
- 碳青霉烯。
- 氟喹诺酮。
- 第二代。
- 第三代。
- 其他。
- 大环内酯类。
- 四环素。
- Other antibiotic classes.
报告亮点
The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.
报告包括
- An overview of the global market for systemic antibiotics.
- 对全球市场趋势的分析，以及2013年的数据，以及2018年复合年增长率（复合年增长率）的预测。
- Details on the factors most impacting the market, including major market growth inhibitors and catalysts.
- Discussion on important trends and products.
- Comprehensive profiles of leading companies in the industry.
报告亮点
- 2008年，当前抗生素和新产品市场的总销售额接近400亿美元。2009年，它增加到415亿美元。到2014年，预计将增加到655亿美元，5年的复合年增长率（CAGR）为5年。9.6％。
- 2008年，最大的细分市场抗生素市场近360亿美元；这进一步增加到2009年的370亿美元，预计2014年的5年复合年增长率为5.9％。
- Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2014, for a 5-year CAGR of 31.6%.
报告亮点
- 在全球范围内，新的和目前可用的抗生素的总市场在2001年达到223亿美元。平均年增长率（AAGR）为9.1％，该市场将在2006年上涨至345亿美元。
- Growth will be driven by new products, whose sales will rise at an AAGR of more than 50% to $7.4 billion in 2006, representing 21% of the total market.
- 2001年的销售额不到10亿美元，仅占市场的4％。
- In 2001, the market for currently available antibiotics was $21.3 billion and is projected to increase at an AAGR of only 4.9% to $27.2 billion by 2006.
- From 2001 to 2006, some 40 new products or formulations could be introduced into the antibiotics sector.
- Many of these drugs will likely prove effective against infectious disease organisms that have developed multidrug resistances, rejuvenating the antibiotics market.